Clinical Trials Browser

Phase 2/3 × Docetaxel × Tumor-Agnostic × Clear all

NCT01523015 2013-02-05

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Phase 2/3 Unknown

Adenocarcinoma